Navigation Links
Astellas Joins the National Pharmaceutical Council
Date:5/14/2013

WASHINGTON, May 14, 2013 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) today announced that Astellas Scientific and Medical Affairs, Inc. (Astellas), a U.S. affiliate of Tokyo-based Astellas Pharma Inc., has joined the health policy research organization as its newest member.  

Located in Northbrook, Illinois, Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. Jeffrey Bloss , M.D., vice president, scientific and medical affairs, will be the company's representative on the NPC board of directors.

"We welcome Dr. Bloss to our board of directors and are looking forward to Astellas' participation in NPC's activities," said NPC President Dan Leonard . "Their perspective will be an invaluable resource for NPC as we continue our mission to educate decision-makers about the tremendous value that the biopharmaceutical industry adds to the health and well-being of Americans."

NPC is actively engaged in conducting health care policy research on topics such as the challenges of individual patient treatment effects, the utilization of real-world evidence and comparative effectiveness research, and understanding the role and value of pharmaceuticals within the current and evolving payment and delivery models.

"We are at an important time of great change with a new health care law, the increasing individualization of drug treatments, and a change in the conversation about those treatments. I look forward to working with NPC as it meets these challenges," said Dr. Bloss. "The biopharmaceutical industry has such an important story to tell, so it is a critical time to be involved with NPC."

About the National Pharmaceutical Council:

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United Sates that supports medical innovation.  Founded in 1953 and supported by the nation's major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients.  For more information visit www.npcnow.org and follow NPC on Twitter @npcnow.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Illinois
2. Astellas and Gift of Hope Organ & Tissue Donor Network Join Forces to Raise Awareness of Need for More Organ Donors in Chicago
3. Astellas Pharma Inc.: New Hire Reinforces Global Compliance Structure
4. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
5. PGA TOUR Celebrates Official Launch of the Astellas Presents Executive Womens Day Program
6. Astellas to Drive PGA TOURs New Womens Initiative
7. Astellas Highlights Progress to Advance Care of Patients with Genitourinary Cancers at ASCO-GU Annual Meeting
8. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
9. Astellas Announces Acceptance of U.S. New Drug Application for Tacrolimus Extended Release Capsules
10. Personal Connections Drive Employee Participation For Changing Tomorrow Day at Astellas
11. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was ... his family verbally and physically. , “When something upset him, he couldn’t control his emotions,” ... He would throw rocks at my other children and say he was going to kill ...
Breaking Medicine News(10 mins):